loading
Schlusskurs vom Vortag:
$14.68
Offen:
$14.72
24-Stunden-Volumen:
967.54K
Relative Volume:
0.17
Marktkapitalisierung:
$7.39B
Einnahmen:
$4.45B
Nettoeinkommen (Verlust:
$205.00M
KGV:
37.21
EPS:
0.4
Netto-Cashflow:
$372.00M
1W Leistung:
+1.80%
1M Leistung:
+10.50%
6M Leistung:
+22.92%
1J Leistung:
+16.20%
1-Tages-Spanne:
Value
$14.66
$14.89
1-Wochen-Bereich:
Value
$14.38
$15.16
52-Wochen-Spanne:
Value
$8.02
$15.78

Elanco Animal Health Inc Stock (ELAN) Company Profile

Name
Firmenname
Elanco Animal Health Inc
Name
Telefon
877-352-6261
Name
Adresse
2500 INNOVATION WAY, GREENFIELD
Name
Mitarbeiter
9,450
Name
Twitter
@Elanco
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
ELAN's Discussions on Twitter

Vergleichen Sie ELAN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
ELAN
Elanco Animal Health Inc
14.88 7.40B 4.45B 205.00M 372.00M 0.40
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
149.47 69.30B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.54 47.50B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.59 44.47B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.24 18.83B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
297.08 13.43B 2.99B 1.21B 1.13B 25.06

Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-07-17 Hochstufung Leerink Partners Market Perform → Outperform
2025-06-26 Hochstufung William Blair Mkt Perform → Outperform
2024-12-09 Eingeleitet UBS Buy
2024-12-02 Eingeleitet Leerink Partners Market Perform
2024-09-19 Herabstufung Morgan Stanley Overweight → Equal-Weight
2024-01-05 Hochstufung Stifel Hold → Buy
2023-12-19 Eingeleitet Jefferies Buy
2023-12-15 Hochstufung Morgan Stanley Equal-Weight → Overweight
2023-12-07 Eingeleitet Exane BNP Paribas Outperform
2023-04-20 Hochstufung Barclays Equal Weight → Overweight
2022-08-18 Herabstufung Morgan Stanley Overweight → Equal-Weight
2022-08-16 Herabstufung JP Morgan Overweight → Neutral
2022-07-21 Herabstufung Goldman Buy → Sell
2022-07-12 Eingeleitet Piper Sandler Neutral
2021-11-18 Eingeleitet Morgan Stanley Overweight
2021-10-28 Herabstufung Stifel Buy → Hold
2021-08-05 Fortgesetzt Credit Suisse Outperform
2021-06-15 Hochstufung Cleveland Research Underperform → Neutral
2021-05-11 Hochstufung Barclays Underweight → Equal Weight
2021-05-11 Hochstufung Gabelli & Co Hold → Buy
2021-04-15 Eingeleitet Stifel Buy
2021-03-22 Herabstufung Gabelli & Co Buy → Hold
2021-02-26 Hochstufung Credit Suisse Neutral → Outperform
2020-12-09 Herabstufung Argus Buy → Hold
2020-11-09 Herabstufung Barclays Overweight → Underweight
2020-08-20 Hochstufung Morgan Stanley Equal-Weight → Overweight
2020-08-13 Fortgesetzt Credit Suisse Neutral
2020-08-04 Fortgesetzt Goldman Buy
2020-07-27 Herabstufung Cleveland Research Neutral → Underperform
2020-04-02 Herabstufung Morgan Stanley Overweight → Equal-Weight
2020-01-10 Eingeleitet Raymond James Mkt Perform
2019-12-19 Hochstufung BofA/Merrill Neutral → Buy
2019-11-07 Hochstufung Morgan Stanley Equal-Weight → Overweight
2019-09-23 Eingeleitet Barclays Overweight
2019-08-26 Herabstufung BofA/Merrill Buy → Neutral
2019-08-15 Hochstufung UBS Sell → Neutral
2019-05-23 Eingeleitet Guggenheim Neutral
2019-03-18 Hochstufung BofA/Merrill Neutral → Buy
2019-03-13 Fortgesetzt Morgan Stanley Equal-Weight
2019-02-12 Eingeleitet William Blair Mkt Perform
2019-01-23 Eingeleitet UBS Sell
2019-01-15 Eingeleitet Argus Buy
2018-10-15 Eingeleitet Morgan Stanley Equal-Weight
Alle ansehen

Elanco Animal Health Inc Aktie (ELAN) Neueste Nachrichten

pulisher
07:13 AM

What drives Elanco Animal Health Incorporated stock priceExplosive portfolio gains - jammulinksnews.com

07:13 AM
pulisher
07:00 AM

What analysts say about Elanco Animal Health Incorporated stockMassive portfolio appreciation - jammulinksnews.com

07:00 AM
pulisher
Jul 21, 2025

Is Elanco Animal Health Incorporated a good long term investmentOverwhelming financial success - Autocar Professional

Jul 21, 2025
pulisher
Jul 21, 2025

Veterinary Oncology Market Growth in Future Scope 2025-2032 | - openPR.com

Jul 21, 2025
pulisher
Jul 21, 2025

Veterinary DermatologyCompany Evaluation Report 2025 | Zoetis, Elanco, and Boehringer Ingelheim Dominate with Global Reach, Innovative Portfolios, and Strategic Expansion - Yahoo Finance

Jul 21, 2025
pulisher
Jul 21, 2025

Leerink Partnrs Has Strong Estimate for ELAN FY2027 Earnings - Defense World

Jul 21, 2025
pulisher
Jul 20, 2025

Xponance Inc. Has $256,000 Stock Holdings in Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World

Jul 20, 2025
pulisher
Jul 20, 2025

Elanco Animal Health Incorporated Stock Analysis and ForecastRecord-breaking capital gains - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 19, 2025

M&T Bank Corp Sells 1,445 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World

Jul 19, 2025
pulisher
Jul 19, 2025

FY2025 Earnings Forecast for ELAN Issued By Leerink Partnrs - Defense World

Jul 19, 2025
pulisher
Jul 19, 2025

Elanco Animal Health (NYSE:ELAN) Raised to “Outperform” at Leerink Partners - Defense World

Jul 19, 2025
pulisher
Jul 18, 2025

Elanco Animal Health (ELAN) Soars 1.34% on Upgrade - AInvest

Jul 18, 2025
pulisher
Jul 18, 2025

Bank of New York Mellon Corp Sells 47,745 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World

Jul 18, 2025
pulisher
Jul 17, 2025

Leerink upgrades Elanco on pet health momentum, downgrades Zoetis By Investing.com - Investing.com Canada

Jul 17, 2025
pulisher
Jul 17, 2025

Elanco Animal Health Inc (ELAN) Stock: A 52-Week Tale of Drops and Gains - investchronicle.com

Jul 17, 2025
pulisher
Jul 17, 2025

This Mondelez International Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday - Benzinga

Jul 17, 2025
pulisher
Jul 17, 2025

Leerink Partners upgrades Elanco Animal Health stock rating to Outperform By Investing.com - Investing.com Canada

Jul 17, 2025
pulisher
Jul 17, 2025

Elanco (ELAN) Upgraded on Promising Pet Health Launches and Grow - GuruFocus

Jul 17, 2025
pulisher
Jul 16, 2025

Elanco launches cattle respiratory vaccine - Beef Magazine

Jul 16, 2025
pulisher
Jul 16, 2025

BiomEdit raises $18.4m Series B to expand designer probiotics platform - AgFunderNews

Jul 16, 2025
pulisher
Jul 15, 2025

Are Options Traders Betting on a Big Move in ELAN Stock? - TradingView

Jul 15, 2025
pulisher
Jul 13, 2025

Elanco Confirms Date and Conference Call for Second Quarter 2025 Financial Results Announcement - ETX View

Jul 13, 2025
pulisher
Jul 10, 2025

Elanco's dog flu vaccine gets USDA nod - MSN

Jul 10, 2025
pulisher
Jul 10, 2025

Neurizon, Elanco sign deal to advance ALS therapy NUZ-001 - ALS News Today

Jul 10, 2025
pulisher
Jul 09, 2025

Elanco gets US Agriculture department nod for TruCan (ELAN:NYSE) - Seeking Alpha

Jul 09, 2025
pulisher
Jul 09, 2025

USDA Approves Elanco's New Vaccine for Canine Influenza - MarketScreener

Jul 09, 2025
pulisher
Jul 09, 2025

Elanco receives USDA nod for Trucan Ultra Civ canine flu vaccine - MarketScreener

Jul 09, 2025
pulisher
Jul 09, 2025

Elanco Receives USDA Approval for TruCan™ Ultra CIV H3N2/H3N8 (Canine Influenza Vaccine) Bringing to Market a High Standard of Respiratory Protection - PR Newswire

Jul 09, 2025
pulisher
Jul 09, 2025

Revolutionary Canine Flu Vaccine Shows 100% Protection: Elanco's New TruCan Ultra Gets USDA Green Light - Stock Titan

Jul 09, 2025
pulisher
Jul 08, 2025

Elanco Animal Health (ELAN) Shares Soar 1.94% Amid KBC Group NV Stake Reduction - AInvest

Jul 08, 2025
pulisher
Jul 06, 2025

Levi & Korsinsky Notifies Elanco Animal Health Incorporated Investors of a Class Action Lawsuit and Upcoming DeadlineELAN - ACCESS Newswire

Jul 06, 2025
pulisher
Jul 03, 2025

Elanco in licensing pact with Australia’s Neurizon (ELAN:NYSE) - Seeking Alpha

Jul 03, 2025
pulisher
Jul 02, 2025

Neurizon Enters into Global License with Elanco to Accelerate Commercialisation of NUZ-001 - Nasdaq

Jul 02, 2025
pulisher
Jul 02, 2025

The Analyst Verdict: Elanco Animal Health In The Eyes Of 4 Experts - Benzinga

Jul 02, 2025
pulisher
Jun 30, 2025

5 Revealing Analyst Questions From Elanco’s Q1 Earnings Call - Yahoo Finance

Jun 30, 2025
pulisher
Jun 28, 2025

Duff & Phelps Provided a Fairness Opinion to Elanco in Connection with its Agreement to Acquire Bayer's Animal Health Business - Kroll

Jun 28, 2025
pulisher
Jun 26, 2025

Elanco Releases 2024 Impact Report and Introduces New Framework - ACCESS Newswire

Jun 26, 2025
pulisher
Jun 26, 2025

Elanco Animal Health: A Catalyst-Driven Revaluation in Agri-Sciences - AInvest

Jun 26, 2025
pulisher
Jun 25, 2025

Elanco Animal Health Amends Receivables Loan Agreement - TipRanks

Jun 25, 2025
pulisher
Jun 20, 2025

Shareholders in Elanco Animal Health (NYSE:ELAN) have lost 37%, as stock drops 3.5% this past week - Yahoo Finance

Jun 20, 2025
pulisher
Jun 18, 2025

Zoetis Stock Is Falling. Why the Animal-Health Company Was Downgraded. - Barron's

Jun 18, 2025
pulisher
Jun 18, 2025

Elanco (ELAN) Gains Attention Amid Competitive Market Shifts | E - GuruFocus

Jun 18, 2025
pulisher
Jun 16, 2025

United States Veterinary Pain Management Market Size, Share & - openPR.com

Jun 16, 2025
pulisher
Jun 14, 2025

Harbor Capital Advisors Inc. Has $9.41 Million Stock Position in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat

Jun 14, 2025
pulisher
Jun 13, 2025

Elanco Receives Positive Opinion on Zenrelia (ilunocitinib) from - GuruFocus

Jun 13, 2025
pulisher
Jun 12, 2025

Elanco (ELAN) Awaits European Approval for Zenrelia in Dogs - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Elanco gains positive EMA opinion for Zenrelia for itching in dogs - Seeking Alpha

Jun 12, 2025
pulisher
Jun 12, 2025

Elanco (ELAN) Awaits EU Approval for Veterinary Drug Zenrelia | ELAN Stock News - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Elanco’s dog allergy treatment Zenrelia gets positive EU opinion By Investing.com - Investing.com Canada

Jun 12, 2025
pulisher
Jun 12, 2025

Elanco Gets 'Positive Opinion' on Canine Itch Drug From European Medicines Agency - marketscreener.com

Jun 12, 2025
pulisher
Jun 12, 2025

Elanco Receives Positive Opinion on Zenrelia (ilunocitinib) from EU's Committee for Veterinary Medicinal Products (CVMP) | ELAN Stock News - GuruFocus

Jun 12, 2025

Finanzdaten der Elanco Animal Health Inc-Aktie (ELAN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$71.33
price down icon 0.37%
$8.98
price up icon 0.45%
drug_manufacturers_specialty_generic RDY
$14.36
price down icon 1.27%
$133.00
price up icon 0.51%
$297.08
price up icon 1.36%
Kapitalisierung:     |  Volumen (24h):